Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?

Primary central nervous system lymphoma (PCNSL) is a rare form and aggressive type of diffuse large B-cell lymphoma (DLBCL) that occurs in both immunocompetent and immunocompromised adults. While adding rituximab to chemotherapeutic regimens resulted in dramatic improvement in both progression-free...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyao, Kotaro, Yokota, Hirofumi, Sakemura, R. Leo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850100/
https://www.ncbi.nlm.nih.gov/pubmed/36686821
http://dx.doi.org/10.3389/fonc.2022.1082235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850100/
https://www.ncbi.nlm.nih.gov/pubmed/36686821
http://dx.doi.org/10.3389/fonc.2022.1082235

Ejemplares similares